Vial code WKZ26T2H
NAD+ 500 mg
- Lot
- NAD-2609A
- Tested
- 9/23/2026
- Lab
- Sample lab (demo data), ISO 17025
- Expires
- 5/23/2028
| Test | Method | Specification | Result | |
|---|---|---|---|---|
| Purity | HPLC | 98% or higher | 99.1% | Pass |
| Identity | Mass spectrometry | Matches reference | Confirmed | Pass |
| Net content | Gravimetric | 500 mg or more | 520 mg | Pass |
| Endotoxin | LAL | Reported | < 0.5 EU/mg | Pass |
| Sterility | USP <71> | No growth | Pass | Pass |
| Heavy metals | ICP-MS | Below limits | Not detected | Pass |
Original report PDF: added when the lab issues it.
| Other lots of NAD+ | Tested | Purity | |
|---|---|---|---|
| NAD-2609B | 9/23/2026 | 99.2% | Report |
All products are sold strictly for in-vitro laboratory research by qualified personnel. They are not drugs, foods, cosmetics or supplements, and are not for human or veterinary use, or for any diagnostic or therapeutic purpose.
NAD+
500 mg · lyophilized powder
Lot WKZ26T2H · 99.1% HPLC$78.99
Save up to 20% on 10+
For research use only. Not for human or veterinary use.